The Bachmann-Strauss Prize for Excellence in Dystonia Research is awarded annually to recognize profound contributions to dystonia research. The award is accompanied by an unrestricted research grant of $100,000 to support further research in the awardee's laboratory.
About the Prize
"To broaden public awareness and recognize key scientific discoveries in dystonia"
In September 2014, The Michael J. Fox Foundation announced a collaborative research alliance with the Bachmann-Strauss Dystonia and Parkinson Foundation and a new prize awarding dystonia research. Since 2015, the Bachmann-Strauss Prize for Excellence in Dystonia Research has been awarded annually to a researcher who has made profound contributions to dystonia research. The award is accompanied by an unrestricted research grant of $100,000 to support further research in the awardee's laboratory.
Eligibility, Selection Process and Criteria
Any researcher who has made significant contributions to the field of dystonia research is eligible to receive the prize. Preference is given to individuals who have made major discoveries with clear patient relevance. The prize may honor current cutting-edge research, an individual's past body of work or both.
A prize committee is chaired and composed of experts in neuroscience research, along with Bonnie Strauss, co-founder of the Bachmann-Strauss Dystonia and Parkinson Foundation. The selection process includes the nominee's:
- complete body of work in the field of dystonia
- leadership contribution to the field of dystonia
- dedication to patient-relevant science
No applications are accepted for the Bachmann-Strauss Prize for Excellence in Dystonia Research. The prize committee has sole authority to nominate and select the prize winner.
Bachmann-Strauss Prize Awardees
2019: Antonio Pisani and David G. Standaert
Antonio Pisani, MD, PhD, associate professor of neurology at the University of Rome Tor Vergata in Italy, and David G. Standaert, MD, PhD, John N. Whitaker Professor and chairman of neurology at The University of Alabama at Birmingham
2018: David Eidelberg
David Eidelberg, MD, professor and head of the Feinstein Institute for Medical Research's Center for Neurosciences and professor of Molecular Medicine and Neurology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
2017: Andres Lozano
Andres Lozano, MD, PhD, professor of neurosurgery at the University of Toronto and Toronto Western Hospital, and a founding member of The Michael J. Fox Foundation's Scientific Advisory Board
2016: Susan Bressman and Laurie Ozelius
Susan Bressman, MD, chair of the Department of Neurology at Mount Sinai Beth Israel, and Laurie Ozelius, PhD, associate neuroscientist and associate professor of neurology at Massachusetts General Hospital and Harvard Medical School
2015: Xandra O. Breakefield
Xandra O. Breakefield, PhD, professor of neurology at Harvard Medical School and geneticist at Massachusetts General Hospital